ESRD. Chronic kidney disease, unspecified
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, vitamin D 50,000 orally will be started for three months, and after three months of consumption, the level of vitamin D will be measured
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients with vitamin D level under 30 ng/dl Willingness to participate in the study (completion of the consent form, interview, completion of the questionnaire) Minimum period of 6 months of dialysis treatment age over 18
Exclusion criteria
Exclusion criteria: Patients who are unable to respond and participate in the study be in treatment with vitamin D
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in vitamin D levels. Timepoint: Before and three months after the intervention. Method of measurement: Vitamin D blood level test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in average pain score. Timepoint: Before and three months after the intervention. Method of measurement: Brief Pain Inventory(Brief Pain Inventory).;Change of the average quality of life score. Timepoint: Before and three months after the intervention. Method of measurement: Quality of life questionnaire(SF36). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Jormand
Hamedan University of Medical Sciences
Outcome results
None listed